Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Skye Bioscience, Inc. - Common Stock (NQ: SKYE )

1.725 -0.005 (-0.29%)
Streaming Delayed Price Updated: 12:30 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 158,958
Open 1.710
Bid (Size) 1.710 (2)
Ask (Size) 1.740 (5)
Prev. Close 1.730
Today's Range 1.630 - 1.750
52wk Range 1.140 - 15.60
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News
Via Stocktwits
Topics Animal Testing Artificial Intelligence Stocks
Exposures Animal Testing Artificial Intelligence Product Safety
Top stock movements in today's session.
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill

Performance

YTD
-39.47%
-39.47%
1 Month
-26.60%
-26.60%
3 Month
-33.40%
-33.40%
6 Month
-66.83%
-66.83%
1 Year
-87.70%
-87.70%

More News

Read More
Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Tuesday's session.
Via Chartmill
Crude Oil Moves Lower; Citigroup Posts Upbeat Results
Via Benzinga
Exposures Fossil Fuels
Nasdaq Surges 100 Points; Bank of America Earnings Top Views
Via Benzinga
Earnings Scheduled For March 20, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Top Picks For 2025: Skye Bioscience
Via Talk Markets
Topics Stocks / Equities
MarketBeat Week in Review – 10/7 - 10/11
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy Interest Rates
Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar
Via MarketBeat
3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore
Via MarketBeat
Topics Bankruptcy
Exposures Financial Legal
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
Via Benzinga
US Stocks Edge Lower; FedEx Earnings Miss Views
Via Benzinga
Topics Earnings
Exposures Financial
Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SKYE Investors Have Opportunity to Join Skye Bioscience, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
From Beacon Biosignals
Via GlobeNewswire
3 Biotech Stocks That Can Gain Exponentially By Leveraging AI
Via Talk Markets
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
Via Investor's Business Daily
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.